CysBio
Kongens Lyngby
About CysBio
Cysbio uses advanced metabolic engineering and synthetic biology approaches to construct bacterial cell factories for transforming the production of biochemicals from renewable feedstocks.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.2M
- Funding stage: Seed
- Last round: Seed (Mar 2019)
- Website: cysbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/cysbio-139072 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.